Different treatments and outcomes of consecutive patients with non-ST-elevation myocardial infarction depending on initial electrocardiographic changes (results of the Acute Coronary Syndromes [ACOS] Registry)

Am J Cardiol. 2004 Jun 15;93(12):1543-6. doi: 10.1016/j.amjcard.2004.02.069.

Abstract

Of 6,302 consecutive patients with acute non-ST-elevation myocardial infarction, 42.8% presented with ST depression, 31.9% showed no significant electrocardiographic changes, and 25.3% presented with T inversion. In comparison with patients with T inversion or no significant electrocardiographic changes, patients with ST depression more often had 3-vessel coronary disease, received less acute therapy despite a strong benefit in a subgroup analysis, and had a worse clinical outcome even after adjustment in a multivariate analysis. Patients with T inversion received a high rate of acute therapy and had a better outcome than did patients without significant electrocardiographic changes and patients with ST depression.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic beta-Antagonists
  • Age Factors
  • Aged
  • Angioplasty, Balloon, Coronary / statistics & numerical data
  • Angiotensin-Converting Enzyme Inhibitors
  • Aspirin / therapeutic use
  • Clopidogrel
  • Coronary Disease / physiopathology
  • Coronary Vessels / pathology
  • Drug Utilization / statistics & numerical data
  • Electrocardiography*
  • Female
  • Germany
  • Hospital Mortality
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Male
  • Multivariate Analysis
  • Myocardial Infarction / mortality
  • Myocardial Infarction / physiopathology*
  • Myocardial Infarction / therapy*
  • Outcome and Process Assessment, Health Care*
  • Platelet Aggregation Inhibitors
  • Recurrence
  • Registries
  • Stroke Volume / physiology
  • Ticlopidine / analogs & derivatives*
  • Ventricular Dysfunction, Left / diagnosis
  • Ventricular Dysfunction, Left / physiopathology

Substances

  • Adrenergic beta-Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Platelet Aggregation Inhibitors
  • Clopidogrel
  • Ticlopidine
  • Aspirin